Your browser doesn't support javascript.
loading
Why TB programmes should assess for comorbidities, determinants and disability at the start and end of TB treatment.
Harries, A D; Lin, Y; Thekkur, P; Nair, D; Chakaya, J; Dongo, J P; Luzze, H; Chimzizi, R; Mubanga, A; Timire, C; Kavenga, F; Satyanarayana, S; Kumar, A M V; Khogali, M; Zachariah, R.
Afiliação
  • Harries AD; International Union Against Tuberculosis and Lung Disease, Paris, France, Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Lin Y; International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Thekkur P; International Union Against Tuberculosis and Lung Disease, Paris, France, The Union-South East (USEA) Office, New Delhi, India.
  • Nair D; International Union Against Tuberculosis and Lung Disease, Paris, France, The Union-South East (USEA) Office, New Delhi, India.
  • Chakaya J; Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya, Respiratory Society of Kenya, Nairobi, Kenya.
  • Dongo JP; The Union-Uganda Office, Kampala, Uganda.
  • Luzze H; National Leprosy and Tuberculosis Programme, Ministry of Health, Kampala, Uganda.
  • Chimzizi R; Ministry of Health/USAID STAR Project, Lusaka, Zambia.
  • Mubanga A; National Tuberculosis Programme, Ministry of Health, Lusaka, Zambia.
  • Timire C; International Union Against Tuberculosis and Lung Disease, Paris, France, Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK, Ministry of Health and Child Care, AIDS and TB Department, Harare, Zimbabwe.
  • Kavenga F; Ministry of Health and Child Care, AIDS and TB Department, Harare, Zimbabwe.
  • Satyanarayana S; International Union Against Tuberculosis and Lung Disease, Paris, France, The Union-South East (USEA) Office, New Delhi, India.
  • Kumar AMV; International Union Against Tuberculosis and Lung Disease, Paris, France, The Union-South East (USEA) Office, New Delhi, India, Yenepoya Medical College, Yenepoya (deemed University), Mangalore, India.
  • Khogali M; Institute of Public Health, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Zachariah R; Special Programme for Research and Training in Tropical Diseases (TDR), WHO, Geneva, Switzerland.
Int J Tuberc Lung Dis ; 27(7): 495-498, 2023 Jul 01.
Article em En | MEDLINE | ID: mdl-37353872
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar Limite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar Limite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2023 Tipo de documento: Article